OBJECTIVES: The aim of the study was to assess quality of life (QoL) in patients with peripheral arterial disease (PAD) after aortobifemoral bypass. METHODS: QoL assessments were completed by 78 patients, 61 (78.2 %) men and 17 (21.8 %) women. QoL was measured, using Medical Outcome Survey Short Form 36 (SF-36), before surgery and 1 year later. RESULTS: QoL significantly improved after revascularization in about two-third of patients with PAD. Improvement was present in all the SF-36 subscales with the exception of the score for mental health which significantly decreased after operation. Mean SF-36 scores, which were for almost all subscales significantly decreased in patients with PAD in comparison with reference populations, after operation reached or exceeded values of the populations with which they were compared. CONCLUSIONS: In the present study 1 year after revascularization QoL in patients with PAD was significantly improved in comparison with QoL before operation. Long-term follow-up is needed in order to assess duration of this beneficial effect of bypass surgery.
OBJECTIVES: The aim of the study was to assess quality of life (QoL) in patients with peripheral arterial disease (PAD) after aortobifemoral bypass. METHODS: QoL assessments were completed by 78 patients, 61 (78.2 %) men and 17 (21.8 %) women. QoL was measured, using Medical Outcome Survey Short Form 36 (SF-36), before surgery and 1 year later. RESULTS: QoL significantly improved after revascularization in about two-third of patients with PAD. Improvement was present in all the SF-36 subscales with the exception of the score for mental health which significantly decreased after operation. Mean SF-36 scores, which were for almost all subscales significantly decreased in patients with PAD in comparison with reference populations, after operation reached or exceeded values of the populations with which they were compared. CONCLUSIONS: In the present study 1 year after revascularization QoL in patients with PAD was significantly improved in comparison with QoL before operation. Long-term follow-up is needed in order to assess duration of this beneficial effect of bypass surgery.
Authors: Päivi E Korhonen; Tellervo Seppälä; Hannu Kautiainen; Salme Järvenpää; Pertti T Aarnio; Sirkka-Liisa Kivelä Journal: Eur J Prev Cardiol Date: 2011-08-11 Impact factor: 7.804
Authors: Corey A Kalbaugh; Spence M Taylor; Dawn W Blackhurst; Matthew B Dellinger; E Annie Trent; Jerry R Youkey Journal: J Vasc Surg Date: 2006-07-11 Impact factor: 4.268
Authors: Louis L Nguyen; Gregory L Moneta; Michael S Conte; Dennis F Bandyk; Alexander W Clowes; B Lynn Seely Journal: J Vasc Surg Date: 2006-11 Impact factor: 4.268
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Sabine Ludt; Michel Wensing; Joachim Szecsenyi; Jan van Lieshout; Justine Rochon; Tobias Freund; Stephen M Campbell; Dominik Ose Journal: PLoS One Date: 2011-12-22 Impact factor: 3.240
Authors: Svenja Petersohn; Bram L T Ramaekers; Renske H Olie; Arina J Ten Cate-Hoek; Jan-Willem H C Daemen; Hugo Ten Cate; Manuela A Joore Journal: Qual Life Res Date: 2019-03-30 Impact factor: 4.147